Share on StockTwits

Masimo Corp. (NASDAQ:MASI) was downgraded by equities researchers at Piper Jaffray to a “neutral” rating in a research report issued on Friday.

Separately, analysts at BTIG Research initiated coverage on shares of Masimo Corp. in a research note on Tuesday, July 8th. They set a “buy” rating and a $32.00 price target on the stock. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $28.60.

Masimo Corp. (NASDAQ:MASI) opened at 24.23 on Friday. Masimo Corp. has a 52 week low of $21.45 and a 52 week high of $32.20. The stock has a 50-day moving average of $24.06 and a 200-day moving average of $25.82. The company has a market cap of $1.375 billion and a price-to-earnings ratio of 21.64.

Masimo Corp. (NASDAQ:MASI) last announced its earnings results on Thursday, August 7th. The company reported $0.24 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.29 by $0.05. The company had revenue of $140.92 million for the quarter, compared to the consensus estimate of $145.76 million. During the same quarter last year, the company posted $0.30 earnings per share. Masimo Corp.’s revenue was up 2.5% compared to the same quarter last year. On average, analysts predict that Masimo Corp. will post $1.28 earnings per share for the current fiscal year.

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products.

Receive News & Ratings for Masimo Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.